Last quarter (Q4 2023), Mersana Therapeutics's total revenue was $10.70M, a decrease of -27.14% from the same quarter last year. In Q4, Mersana Therapeutics's net income was $-19.54M. See Mersana Therapeutics’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Total Revenue	$ 36.85M	$ 36.85M	$ 26.58M	$ 43.00K	$ 828.00K	$ 42.12M
Cost of Revenue	-	-	-	-	-	-
Gross Profit	$ 36.85M	$ 36.85M	$ 26.58M	$ 43.00K	-	-
Operating Expense	$ 216.53M	$ 216.53M	$ 230.35M	$ -168.90M	$ 88.94M	$ 72.32M
Operating Income	$ -170.96M	$ -170.96M	$ -203.77M	$ -168.86M	$ -88.11M	$ -30.20M
Net Non Operating Interest Income Expense	$ 8.00M	$ 8.00M	$ -445.00K	$ -1.20M	$ 65.00K	$ 1.99M
Other Income Expense	$ -27.87M	$ -27.87M	-	$ -43.00K	-	-
Pretax Income	$ -171.67M	$ -171.67M	$ -204.21M	$ -170.06M	$ -88.05M	$ -28.21M
Tax Provision	-	-	-	-	-	-
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -227.83M	$ -171.67M	$ -204.21M	$ -340.12M	$ -88.05M	$ -28.21M
Basic EPS	$ -1.50	$ -1.48	$ -2.18	$ -2.41	$ -1.43	$ -0.65
Diluted EPS	$ -1.50	$ -1.48	$ -2.18	$ -2.41	$ -1.43	$ -0.65
Basic Average Shares	$ 464.45M	$ 116.11M	$ 93.65M	$ 70.58M	$ 61.49M	$ 43.49M
Diluted Average Shares	$ 464.45M	$ 116.11M	$ 93.65M	$ 70.58M	$ 61.49M	$ 43.49M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 216.53M	$ 216.53M	$ 230.35M	$ -168.90M	$ 88.94M	$ 72.32M
Net Income From Continuing And Discontinued Operation	$ -171.70M	$ -171.70M	$ -204.20M	$ -170.06M	$ -88.05M	$ -28.21M
Normalized Income	$ -39.63M	$ -126.91M	$ -161.33M	-	$ -88.05M	$ -28.21M
Interest Expense	-	-	-	-	$ 359.00K	$ 234.00K
EBIT	$ -167.60M	$ -167.60M	$ -200.88M	$ -168.79M	$ -87.69M	$ -27.97M
EBITDA	$ -170.65M	$ -170.65M	$ -201.42M	$ -167.94M	$ -86.68M	$ -26.73M

Currency in USD

Mersana Therapeutics Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing